Sponsor:
Astellas Pharma Global Development, Inc.
Code:
NCT07024615
Conditions
Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ASP2138
Oxaliplatin
Leucovorin
5-FU
Irinotecan
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-29. This information was provided to ClinicalTrials.gov by Astellas Pharma Global Development, Inc. on 2026-03-13.